Infection with hepatitis A virus (HAV) is one of the common causes of liver disease of great public health importance in the world. However, the level of endemicity, the median age at the time of infection, and the frequency of clinically apparent hepatitis caused by HAV vary by population.
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Viral Hepatitis in Mongolia: Past, Present, and Future Bira Tsatsralt-Od sively transferred maternal antibody against HAV within 6 months of life. 2 Then, the prevalence of anti-HAV increased from 1 to 20 years of age, being 19.5% in the age group 1 to 3 years, 50% in the age group 4 to 6 years, and > 80% in the age group 7 to 9 years. Nearly all subjects (97.2%) in the age group 16 to 20 years had anti-HAV. 3 This is in agreement with our previous observation that all 249 apparently healthy adults aged 23 to 86 years were immune against HAV. 4 Subgenotype IA HAV was recovered from all 3 children with current infection with HAV, confirming results from a previous study that subgenotype IA was prevalent among patients with hepatitis A in Mongolia. 2 The
Mongolian HAV isolates were more closely related over the entire genome to those circulating in China and Japan. The seroprevalence of two hepatitis viruses, HAV and HEV, transmitted enterically were compared. Hepatitis A virus and HEV had different epidemiological patterns in the Mongolian children, and only 5 children (0.7%) were found to be positive for anti-HEV IgG. 2 The very low prevalence of HEV infection among children found in this study is in contrast to a study in the adult population in which as high as 11% were positive for anti-HEV IgG. 4 In 
